Immune-mediated haemolytic anaemia (IMHA) is a condition not infrequently encountered in general practice. Making that initial diagnosis and having the evidence and confidence to appropriately immunosuppress is sometimes easier said than done.
This presentation will go through IMHA from presentation of a patient with regenerative anaemia, to how you can make a confident diagnosis. The current recommendations in terms of treatment options, when to start second line immunosuppressives, and when can these patients be discharged. It'll finish up with some novel treatment options and decision making as to how to wean the medications if all is going well.
Recorded 24 March 2026
Puhuja:
Craig Breheny
BVM&S, DipECVIM-CA, MRCVS
Craig graduated from the Royal (Dick) School of Veterinary Studies in 2011. He spent several years in a busy general practice in the Northeast of England before returning for a residency in Internal Medicine.
Craig has stayed on and is one of the Co-Heads of the Emergency & Critical Care Department. His main research interests are acute medicine and immune-mediated diseases.
